日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Response to "Letter to the Editor Regarding 'Dupilumab Versus Lebrikizumab Demonstrates Greater Likelihood of Achieving and Maintaining Improvements in Efficacy Outcomes Using a Placebo-Adjusted Indirect Treatment Comparison'"

对“致编辑的信,内容为‘使用安慰剂调整的间接治疗比较,Dupilumab 与 Lebrikizumab 显示出更有可能实现和维持疗效结果的改善’”的回应

Ständer, Sonja; Pinter, Andreas; Hougeir, Firas G; Guyot, Patricia; Xu, Yingxin; Praestgaard, Amy H; Freemantle, Nick; Rossi, Ana B; Bégo-Le-Bagousse, Gaëlle; Wang, Zhixiao; Noonan, Kerry; Bastian, Mike

Efficacy and Safety of Dupilumab in Adults with Prurigo Nodularis with or Without Atopic Comorbidities: A Subgroup Analysis from Two Randomized Phase III Clinical Trials

Dupilumab治疗伴或不伴特应性合并症的成人结节性痒疹的疗效和安全性:两项随机III期临床试验的亚组分析

Kim, Brian S; Gonçalo, Margarida; Ugajin, Tsukasa; Gao, Xing-Hua; Praestgaard, Amy H; Makhija, Melanie; Zahn, Joseph; Bansal, Ashish; Wiggins, Simmi

Dupilumab versus Lebrikizumab Demonstrates Greater Likelihood of Achieving and Maintaining Improvements in Efficacy Outcomes Using a Placebo-Adjusted Indirect Treatment Comparison

与Lebrikizumab相比,Dupilumab在安慰剂调整的间接治疗比较中显示出更高的疗效改善实现和维持的可能性。

Ständer, Sonja; Pinter, Andreas; Hougeir, Firas G; Guyot, Patricia; Xu, Yingxin; Praestgaard, Amy H; Freemantle, Nick; Rossi, Ana B; Bégo-Le-Bagousse, Gaëlle; Wang, Zhixiao; Noonan, Kerry; Bastian, Mike

Optimal Itch Response in Adults Treated with Dupilumab for Moderate-to-Severe Atopic Dermatitis

使用度普利尤单抗治疗中重度特应性皮炎的成人患者可获得最佳止痒效果

Ständer, Sonja; Yosipovitch, Gil; Kim, Brian S; Steinhoff, Martin; Armstrong, April; Legat, Franz J; Kabashima, Kenji; Nakahara, Takeshi; Igarashi, Atsuyuki; Praestgaard, Amy H; Nguyen, Tien V; Bastian, Mike

Evaluating Meaningful Changes in Patient-Reported Outcome Measurement Information System-Fatigue Scores from Three Phase 3 Clinical Trials of Sarilumab for Patients With Rheumatoid Arthritis

评估沙利鲁单抗治疗类风湿性关节炎患者的三项 3 期临床试验中患者报告结局测量信息系统疲劳评分的显著变化

Bingham, Clifton O; Molina, Emily; Praestgaard, Amy; Fiore, Stefano; Cella, David

Efficacy and Safety of Dupilumab Treatment with Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis

度普利尤单抗联合局部皮质类固醇治疗6个月至5岁重度特应性皮炎患儿的疗效和安全性

Paller, Amy S; Pinter, Andreas; Wine Lee, Lara; Aschoff, Roland; Zdybski, Jacek; Schnopp, Christina; Praestgaard, Amy; Bansal, Ashish; Shumel, Brad; Prescilla, Randy; Bastian, Mike

Correction to: Efficacy and Safety of Dupilumab Treatment with Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis

更正:度普利尤单抗联合局部皮质类固醇治疗6个月至5岁重度特应性皮炎患儿的疗效和安全性

Paller, Amy S; Pinter, Andreas; Wine Lee, Lara; Aschoff, Roland; Zdybski, Jacek; Schnopp, Christina; Praestgaard, Amy; Bansal, Ashish; Shumel, Brad; Prescilla, Randy; Bastian, Mike

Dupilumab improves outcomes in patients with chronic rhinosinusitis with nasal polyps irrespective of gender: results from the SINUS-52 trial

Dupilumab 可改善伴有鼻息肉的慢性鼻窦炎患者的预后,且与性别无关:SINUS-52 试验结果

Fokkens, Wytske J; Bachert, Claus; Hopkins, Claire; Marglani, Osama; Praestgaard, Amy; Nash, Scott; Deniz, Yamo; Rowe, Paul J; Sacks, Harry; Jacob-Nara, Juby A

Correction: Real-World Sarilumab Use and Rule Testing to Predict Treatment Response in Patients with Rheumatoid Arthritis: Findings from the RISE Registry

更正:真实世界中 Sarilumab 的应用及预测类风湿性关节炎患者治疗反应的规则检验:来自 RISE 注册研究的发现

Curtis, Jeffrey R; Yun, Huifeng; Chen, Lang; Ford, Stephanie S; van Hoogstraten, Hubert; Fiore, Stefano; Ford, Kerri; Praestgaard, Amy; Rehberg, Markus; Choy, Ernest

Association of hemoglobin levels with radiographic progression in patients with rheumatoid arthritis: an analysis from the BRASS registry

类风湿性关节炎患者血红蛋白水平与放射学进展的相关性:来自BRASS注册研究的分析

Shadick, Nancy; Hagino, Owen; Praestgaard, Amy; Fiore, Stefano; Weinblatt, Michael; Burmester, Gerd